Soricimed Biopharma Inc. is collaborating with Mount Allison University to design and develop new biologic drug conjugates for oncology based on the company's proprietary drug delivery system. The research will involve attaching cancer drugs to one of Sorcimed's targeted oncology drugs, SOR-C27, which binds directly to cancer tumours. The ultimate goal of the collaboration is to advance the efficacy of chemotherapy drugs while reducing the treatment's traumatic side effects.

Dr. Karen R. Grant has been appointed to a five-year term as Mount Allison University's Provost and Vice-President, Academic and Research effective August 1, 2012. Grant is currently the Vice-Provost (Academic Affairs) at the University of Manitoba. She is a professor in the Department of Sociology specializing in health sociology and women's health.

Mount Allison University Presents at 2011 Canadian Science Policy Conference, Nov-18-2011 10:30 AM. Venue: Ottawa Convention Centre, Ottawa, Ontario, Canada. Speakers: Ian Mauro, Canada Research Chair in Human Dimensions of Environmental Change.